Icosavax, Inc.
ID: 5874867A biotechnology company in Washington that focuses on developing safe and effective vaccines against infectious diseases.
4
Funding Rounds
$385.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ad** Si***** | - | - | |
| Da*** Ba*** |
|
- | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ad** Si***** | - | - | |
| An* Ve***** | - | - | - |
| Ma** Mc**** | - | - | - |
| Pe*** Ko******** | - | - |
Funding series
Funding Series Analysis
The company Icosavax, Inc. has raised a total of $282m in funding over 4 rounds.
Key Insights:
- Icosavax, Inc. Initial public offering (IPO): $182m
- Icosavax, Inc. funding round, April 2021: $100m
- Icosavax, Inc. funding round, October 2019: $51.01m
- Icosavax funding round, October 2019: $52m
Industries
Icosavax, Inc. is active in the following industries: